Cargando…

Burden of Disease Among Exacerbating Patients with COPD Treated with Triple Therapy in Spain

BACKGROUND: The cost of chronic obstructive pulmonary disease (COPD) in Spain has been studied from different perspectives, but parameters such as the patient’s phenotype have seldom been considered. Our aim was to describe the disease burden of COPD patients with frequent exacerbator phenotype, tre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alcázar-Navarrete, Bernardino, García-Rio, Francisco, Sánchez, Guadalupe, Mariscal, Esther, García, Andrea, Cuesta, Maribel, Uría, Estefany, Miravitlles, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312318/ https://www.ncbi.nlm.nih.gov/pubmed/34321874 http://dx.doi.org/10.2147/COPD.S310319

Ejemplares similares

The concept of control of COPD in clinical practice
por: Soler-Cataluña, Juan José, et al.
Publicado: (2014)

Generic utilities in chronic obstructive pulmonary disease patients stratified according to different staging systems
por: Miravitlles, Marc, et al.
Publicado: (2014)

Validation of clinical control in COPD as a new tool for optimizing treatment
por: Soler-Cataluña, Juan José, et al.
Publicado: (2018)

Geographic variations of the prevalence and distribution of COPD phenotypes in Spain: “the ESPIRAL-ES study”
por: Alcázar-Navarrete, Bernardino, et al.
Publicado: (2018)

Real-life burden of hospitalisations due to COPD exacerbations in Spain
por: Izquierdo, José Luis, et al.
Publicado: (2022)

Impact of COPD Exacerbations and Burden of Disease in Spain: AVOIDEX Study
por: Soler-Cataluña, Juan José, et al.
Publicado: (2023)

Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD
por: Miravitlles, Marc
Publicado: (2007)

Clinical Features Of Women With COPD: Sex Differences In A Cross-Sectional Study In Spain (“The ESPIRAL-ES Study”)
por: Trigueros, Juan Antonio, et al.
Publicado: (2019)

Optimizing bronchodilation in the prevention of COPD exacerbations
por: Miravitlles, Marc, et al.
Publicado: (2017)

Testing for alpha-1 antitrypsin in COPD in outpatient respiratory clinics in Spain: A multilevel, cross-sectional analysis of the EPOCONSUL study
por: Calle Rubio, Myriam, et al.
Publicado: (2018)

Correction: Testing for alpha-1 antitrypsin in COPD in outpatient respiratory clinics in Spain: A multilevel, cross-sectional analysis of the EPOCONSUL study
por: Calle Rubio, Myriam, et al.
Publicado: (2019)

Understanding the impact of symptoms on the burden of COPD
por: Miravitlles, Marc, et al.
Publicado: (2017)

Clinical audit of COPD in outpatient respiratory clinics in Spain: the EPOCONSUL study
por: Calle Rubio, Myriam, et al.
Publicado: (2017)

Determinants in the Underdiagnosis of COPD in Spain—CONOCEPOC Study
por: Calle Rubio, Myriam, et al.
Publicado: (2022)

Caregivers’ burden in patients with COPD
por: Miravitlles, Marc, et al.
Publicado: (2015)

Impact and prevention of severe exacerbations of COPD: a review of the evidence
por: Halpin, David MG, et al.
Publicado: (2017)

Unravelling young COPD and pre-COPD in the general population
por: Cosío, Borja G., et al.
Publicado: (2023)

Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review
por: Miravitlles, Marc, et al.
Publicado: (2016)

Relationship Between Clinical Control, Respiratory Symptoms and Quality of Life for Patients with COPD
por: Alcazar-Navarrete, Bernardino, et al.
Publicado: (2020)

Inhaled Corticosteroid Use Among COPD Patients in Primary Care in Spain
por: Miravitlles, Marc, et al.
Publicado: (2022)

Independent effect of prior exacerbation frequency and disease severity on the risk of future exacerbations of COPD: a retrospective cohort study
por: Margüello, Miguel Santibañez, et al.
Publicado: (2016)

Economic Impact of Low Adherence to COPD Management Guidelines in Spain
por: Miravitlles, Marc, et al.
Publicado: (2021)

A Delphi Consensus Document on the Use of Single-Inhaler Fixed-Dose Triple Therapies in COPD Patients
por: López-Campos, José Luis, et al.
Publicado: (2020)

Cost-effectiveness of combination therapy umeclidinium/vilanterol versus tiotropium in symptomatic COPD Spanish patients
por: Miravitlles, Marc, et al.
Publicado: (2016)

Course of COPD assessment test (CAT) and clinical COPD questionnaire (CCQ) scores during recovery from exacerbations of chronic obstructive pulmonary disease
por: Miravitlles, Marc, et al.
Publicado: (2013)

Epidemiological Evolution of Lung Cancer in the South of Spain from 1990 to 2010
por: Vázquez, Alberto Caballero, et al.
Publicado: (2018)

Economic burden of recurrent Clostridioides difficile infection in adults admitted to Spanish hospitals. A multicentre retrospective observational study
por: Bouza, Emilio, et al.
Publicado: (2021)

Prognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPD
por: Wilson, Robert, et al.
Publicado: (2015)

The evaluation of a remote support program on quality of life and evolution of disease in COPD patients with frequent exacerbations
por: Alcazar, Bernardino, et al.
Publicado: (2016)

Treatment of patients with COPD and recurrent exacerbations: the role of infection and inflammation
por: Santos, Salud, et al.
Publicado: (2016)

Bronchiectasis in COPD patients: more than a comorbidity?
por: Martinez-Garcia, Miguel Angel, et al.
Publicado: (2017)

Characteristics and treatment patterns of patients with asthma on multiple-inhaler triple therapy in Spain
por: Barrecheguren, Miriam, et al.
Publicado: (2022)

Impact of Hyponatremia on COPD Exacerbation Prognosis
por: García-Sanz, María-Teresa, et al.
Publicado: (2020)

The chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPD
por: Miravitlles, Marc, et al.
Publicado: (2015)

A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology
por: Wilson, Robert, et al.
Publicado: (2011)

Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results
por: Wilson, Robert, et al.
Publicado: (2012)

Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME study
por: Vogelmeier, Claus F, et al.
Publicado: (2018)

The Impact of Chronic Bronchial Infection in COPD: A Proposal for Management
por: Martinez-Garcia, Miguel Angel, et al.
Publicado: (2022)

The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK
por: Brusselle, Guy, et al.
Publicado: (2015)

The IMPACT of triple versus dual single-inhaler therapy on exacerbations of COPD
por: Dobler, Claudia C.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jq0r0hv4j88gq80g5058jm4d9s